The North America IoT Medical Devices Market is a rapidly evolving segment in the healthcare landscape, driven by the accelerating adoption of connected health solutions and digital medicine. In 2025, the market size was valued at USD 24,560 Million and is projected to reach USD 97,320 Million by 2035, expanding at a CAGR of 14.2% during the forecast period 2024-2035. Increasing demand for remote patient monitoring, along with the growing elderly population, is expected to further boost the market growth across the region.
The economic impact of tariffs on "North America IoT Medical Devices Market".
Market Growth Drivers
Rising Demand for Remote Patient Monitoring: As chronic diseases become increasingly prevalent in North America, healthcare providers are leveraging IoT medical devices for effective remote monitoring. Abbott Laboratories’ FreeStyle Libre and Medtronic’s Guardian Connect continually transmit critical health data to medical professionals, drastically improving patient outcomes through real-time intervention and reducing unnecessary hospital visits.
Increasing Adoption of Telehealth Services: The surge in telehealth across the United States and Canada has driven healthcare systems to integrate IoT-enabled devices such as wearable ECG monitors and smart insulin pumps. Companies like Philips and Dexcom have partnered with telehealth providers to streamline data flows, enabling clinicians to remotely monitor patients’ health parameters and deliver personalized care, vastly improving resource allocation and accessibility.
Market Trends
Integration of AI and Machine Learning: AI-powered IoT devices are transforming clinical workflows by enabling predictive analytics for disease management. In 2023, GE Healthcare launched its Edison platform integrating AI with IoT-enabled diagnostic equipment, allowing healthcare providers to detect anomalies faster and predict patient deterioration using real-time analytics.
Expansion of Blockchain for Data Security: With security and privacy concerns rising, IoT medical device manufacturers are adopting blockchain frameworks. In April 2024, IBM Watson Health collaborated with Wipro to pilot blockchain-based solutions that help secure the transmission of sensitive medical data from IoT devices, providing immutable audit trails and complying with HIPAA and other regulatory standards.
Market Opportunity
Increasing Use in Home Healthcare: The demand for IoT medical devices in home healthcare is projected to surge as more patients opt for at-home health monitoring. Boston Scientific’s LUX-Dx Insertable Cardiac Monitor is an example of such innovations, providing patients and clinicians with round-the-clock insights while reducing hospital admissions.
Adoption in Chronic Disease Management: IoT devices hold immense potential for the management of chronic conditions such as diabetes and COPD. Dexcom’s continuous glucose monitoring systems, for instance, provide real-time updates to both patients and healthcare providers, leading to more proactive and personalized treatment.
North America IoT Medical Devices Market Revenue (USD Million), 2020-2035
The chart illustrates a robust upward trajectory in the North America IoT Medical Devices Market from 2020 to 2035. The market was valued at USD 8,100 Million in 2020, steadily growing amid the digitization of healthcare and the surge in remote monitoring needs. By 2025, the market reached USD 24,560 Million, and is forecasted to increase rapidly, with significant jumps post-2030, culminating at USD 97,320 Million by 2035. This reflects a strong compound annual growth rate of 14.2%, showcasing the region’s swift adoption of IoT healthcare innovations and the broadening use of remote care technologies.
North America IoT Medical Devices Market Share by Region (%) in 2025
The 2025 regional market share pie chart shows the United States dominating the North America IoT Medical Devices Market with 68%, driven by its advanced healthcare infrastructure, early adoption of digital health, and presence of key players like Medtronic and GE Healthcare. Canada holds the second-largest share at 20%, reflecting growing investments and supportive regulatory frameworks. Mexico accounts for 7% as it accelerates healthcare digitization, while other smaller regions (Caribbean and Central America) together represent 5%. The distribution highlights competitive growth opportunities beyond the U.S., especially as digital health expands regionwide.
Recent Market Developments
In March 2024, Medtronic received U.S. FDA approval for its next-generation IoT-enabled MiniMed 780G insulin pump system across North America. The device leverages intelligent connectivity and cloud analytics, allowing real-time data sharing between patients and healthcare teams for improved glucose management decisions.
In April 2024, Philips expanded its partnership with Teladoc Health to integrate the Philips Biosensor BX200—a wearable IoT device—for continuous remote monitoring of high-risk patients discharged from hospitals. This collaboration aims to reduce readmission rates by providing actionable insights to clinicians via a secure cloud platform.
Johnson & Johnson announced in May 2024 the launch of its IoT-based Home Health Hub in select U.S. states. The solution integrates multiple connected medical devices—ranging from blood pressure monitors to smart inhalers—enabling consolidated patient data tracking, reinforced by AI-based risk assessment and early intervention capabilities.
Wearable Medical Devices, Stationary Medical Devices, Implantable Medical Devices, Other IoT Medical Devices, Remote Patient Monitoring Devices, Diagnostic Devices, Patient Monitoring, Clinical Operation & Workflow Optimization, Connected Imaging, Telemedicine, Drug Delivery, Other Applications, Bluetooth, Wi-Fi, Zigbee, Cellular, RFID, Other Technologies, Direct Tenders, Retail Sales, Online Sales, Distributors, Wholesalers, Other Channels, Small, Medium, Large
Press Releases